Renal Advantage and Liberty Dialysis said the two privately held dialysis companies reached a deal described as a merger under a holding company, a spokesman said. Terms of the deal were not disclosed. Private-equity firms Bain Capital, KRG Capital Partners and Ignition Partners, investors in Liberty Dialysis, will continue to have a stake in the combined companies, said Todd Smith, a spokesman for the companies. Liberty Dialysis, Mercer Island, Wash., operates 112 dialysis clinics. Renal Advantage—operating with financing from private-equity firm Welsh, Carson, Anderson & Stowe—runs 150 dialysis centers in 19 states and has annual revenue of $465 million. The deal is expected to close by year-end.
Two dialysis companies agree to merger deal
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You